Optimizing treatment for cervical cancer: The value of chemoradiation

American Journal of Cancer

Volumn 3, Issue 4, 2004, Pages 215-227

  Green, John A ^a   Lopes, Alberto De Barros ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA;

ADVANCED CANCER; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CYTOTOXICITY; EVALUATION; FERTILITY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MORBIDITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RADIOSENSITIZATION; RECURRENCE RISK; REVIEW; RISK FACTOR; UTERINE CERVIX CANCER; VALIDATION PROCESS;

EID: 10044233896     PISSN: 11756357     EISSN: None     Source Type: Journal    
DOI: 10.2165/00024669-200403040-00002     Document Type: Review

References (76)

1. Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29
2. Benedet J, Odicino F, Maisonneuve P, et al. FIGO annual report 1990-1992. J Epidemiol Biostat 1998; 3(1): 1-34
3. Delgado G, Bundy B, Zaino R, et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990; 38: 352-7
4. Heller PB, Malfetano JH, Bundy BN, et al. Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis - a Gynecological Oncology Group study. Gynecol Oncol 1990; 38: 425-30
5. Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomised study. J Clin Oncol 2002; 20: 179-88
6. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154-61
7. Perez CA, Kurman RJ, Stehman FB, et al. Uterine cervix. In: Hoskins WJ, Perez CA, Young RC, editors. Principles and practice of gynecologic oncology. 1st ed. Philadelphia (PA): Lippincott, 1992: 594
8. Wallner KE, Li GC. Effect of cisplatin resistance on cellular radiation response. Int J Radiat Oncol Biol Phys 1987; 131: 587-91
9. Omura G A. Chemotherapy for stage IVB or recurrent cancer of the uterine cervix. J Natl Cancer Inst 1996; 21: 123-6
10. Moore DH, McQuellon RP, Blessing JA, et al. A randomized phase III study of cisplatin versus cisplain plus paclitaxel in stage IVB, recurrent or persistent squamous cell carcinoma of the cervix. Proc Soc Gynecol Oncol 2001; 32: 21
11. Bloss JD, Blessing JA, Behrens BC, et al. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 2002; 20: 1832-7
12. Steele GG. The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol 1988; 11: 31-55
13. Tierney JF, Stewart LA, Parmar MKB. Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix? Eur J Cancer 1999; 35: 406-9
14. Tierney JF, Stewart LA. Neoadjuvant chemotherapy followed by radiotherapy for locally advanced cervix cancer: a meta-analysis using individual patient data from randomised controlled trials (RCTs). Proc Am Soc Clin Oncol 2002; 20 (1): 179-88
15. Fyles A, Milosevic M, Hedley D, et al. Tumor hypoxia has independent predictive impact only in patients with node-negative cervix cancer. J Clin Oncol 2002; 20: 680-7
16. Wong LC, Ngan HYS, Cheung ANY, et al. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol 1999; 17: 2055-60
17. Lanciano RM, Pajak TF, Martz K, et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study. Int J Radiat Oncol Biol Phys 1993; 25: 391-7
18. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. The Lancet 2001; 358: 781-6
19. Pearcey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002; 20: 966-72
20. Thomas G, Dembo A, Ackerman I, et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. Gynecol Oncol 1998; 69: 137-4
21. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Eng J Med 1999; 340: 1137-43
22. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-53
23. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecological Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17: 1339-48
24. Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606-13
25. Roberts KB, Urdaneta N, Vera R, et al. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous cell carcinoma of the cervix. Int J Cancer 2000; 90: 206-23
26. Tseng CJ, Chang CT, Lai CH, et al. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 1997; 66
27. Lira-Puerto V, De-la Huerta R, Cortes H, et al. Cisplatin (CDDP) plus radiotherapy (RT) versus radiotherapy alone in locally advanced cervical cancer. [abstract] Proc Am Soc Clin Oncol 1990; 9: 633
28. Singh P, Dharmalingam SK, Tan MK, et al. Chemotherapy-radiotherapy combination in the treatment of carcinoma of the cervix. Souteast Asian J Trop Med Public Health 1985; 16: 665-8
29. Hong Wei C, Junjie F, Mingzhong I, et al. The effect of randomized trial of hyperthermo-radiochemotherapy for carcinoma of the cervix. Chin J Oncol 1997; 24: 249-51
30. Lorvidhaya V, Chitapanaux I, Sangruchi S, et al. Concurrent mitomycin C, 5 fluorouracil and readiotherapy in teh treatment of locally advanced carcinoma of the cervix: a randomized trial. Int J Radiat Oncol Biol Phys 2003; 55: 1226-32
31. Wong LC, Choo YC, Choy D, et al. Long-term follow up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer. Gynecol Oncol 1989; 35: 159-63
32. Hernandez JR, de la Huerta Sanchez R, Morales Canfield F, et al. Uterine cervix cancer: clinical stage III. Combined radiotherapy and chemotherapy treatment. Ginecol Obstet Mex 1991; 59: 238-42
33. Pignon JP, Hill C. Meta-analyses of randomised clinical trials in oncology. Lancet Oncol 2001; 2: 475-82
34. Lukka H, Hirte H, Fyles A, et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis. Clin Oncol 2002, 212
35. Rose PG, Bundy BN. Chemoradiation for locally advanced cervical cancer: does it help? J Clin Oncol 2002; 20: 891-3
36. Thomas GM. Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin Radiat Oncol 2000; 10: 44-50
37. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group (RTOG). J Clin Oncol 2004; 22: 90-101
38. NCI Alert [online]. Available from URL: http://www.nci.nih.gov/ clinicaltrials/development/excerpt-announcement0300 [Accessed 2004 Mar 2]
39. Griniski T, Pejovic-Lenfant MH, Bourhis J, et al. Prognostic value of haemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 1989; 16: 37-42
40. Grogan M, Thomas GM, Melamed I, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999; 86: 1528-36
41. Blohmer JU, von Minckwitz G, Paepke S, et al. Sequential adjuvant chemoradiotherapy with vs without erythropoeitin for patients with high-risk cervical cancer-second analysis of a prospective, randomized, open and controlled AGO- and NOGGO-intergroup study [abstract]. Proc Am Soc Clin Oncol 2002; 21: 207a
42. Kirwan JM, Symonds P, Green JA, et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003; 68: 217-26
43. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-flurouracil, and mitomycin. Lancet 1996; 348: 1049-54
44. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000; 355: 949-55
45. Cole BF, Gelber RD, Gelber S, et al. Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis. Lancet 2001; 358: 277-86
46. Morris M. Management of stage IA cervical carcinoma. Monographs. J Natl Cancer Inst. 1996; 21: 47-52
47. Morgan PR, Anderson MC, Buckley CH, et al. The Royal College of Obstetricians and Gynaecologists micro-invasive carcinoma of the cervix study: preliminary results. Br J Obstet Gynaecol 1993; 100: 664-8
48. Winter R. Conservative surgery for microinvasive carcinoma of the cervix. J Obstet Gynaecol 1998; 24: 433-6
49. Vaegashi N, Sato S, Inoue Y. Conservative surgical treatment in cervical cancer with 3 to 5 mm stromal invasion in the absence of confluent invasion and lymph-vascular space involvement. Gynecol Oncol 1994; 54: 333-7
50. Buckley SL, Tritz DM, Van-Le L, et al. Lymph node metastases and prognosis in patients with stage IA2 cervical cancer. Gynecol Oncol 1996; 63: 4-9
51. Piver MS, Rutledge F, Smith JP, et al. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynaecol 1974; 44: 265-72
52. Landoni F, Maneo A, Cormio G. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol 2001; 80: 3-12
53. Sedlis A, Bundy BN, Rotman MZ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol 1999; 73 (2): 177-83
54. Curtin JP, Hoskins WJ, Vantatraman ES, et al. Adjuvant chemotherapy versus chemotherapy plus pelvic radiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial. Gynecol Oncol 1996; 61: 3-10
55. Querleu D, Dargent D, Ansquer Y, et al. Extraperitoneal endosurgical aortic and common iliac dissection in the staging of bulky or advanced cervical carcinomas. Cancer 2000; 88 (8): 1883-91
56. Sardi JE, Giarolo A, Sananes C, et al. Long-term follow up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 1997; 67: 61-9
57. Sardi J, Giaroli A, Sannanes C, et al. A randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma of the cervix uteri: an unexpected therapeutic management. Int J Gynecol Cancer 1996; 6: 85-93
58. Sardi J, Sananes C, Giaroli A, et al. Neoadjuvant chemotherapy in cervical carcinoma stage IIB: a randomized controlled trial. Int J Gynecol Cancer 1998; 8: 441-50
59. Dargent D, Ansquer Y, Mathevet P, et al. Technical development and results of left extraperitoneal laparoscopic paraaortic lymphadenectomy for cervical cancer. Gynecol Oncol 2000; 77 (1): 87-92
60. Occelli B, Narducci F, Lanvin D, et al. De novo adhesions with extraperitoneal endosurgical para-aortic lymphadenectomy versus transperitoneal laparoscopic para-aortic lymphadenectomy: a randomized experimental study. Am J Obstet Gynecol 2000; 183 (3): 529-33
61. Dargent D, Martin X, Sacchetoni A, et al. Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer 2000; 88: 1877-82
62. Shepherd JH, Mould T, Oram DH. Radical trachelectomy in early stage carcinoma of the cervix: outcome as judged by recurrence and fertility rates. Br J Obstet Gynaecol 2001; 108 (8): 882-5
63. Covens A, Rosen B, Murphy J, et al. How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol 2002; 84 (1): 145-9
64. Covens A, et al. Differences in the morbidity of radical hysterectomy between gynaecological oncologists. Gynecol Oncol 1993; 51: 39-45
65. John MJ. Grading of chemoradiation toxicity. In: John MJ, Flam MS, Legha SS, et al., editors. Chemoradiation: an integrated approach to cancer treatment. Philadelphia (PA); Lea and Febiger, 1993: 601-6
66. Eifel PJ, Levenback C, Oswald MJ. The time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994; 30: 212
67. Arbuck SG, Setser A, Ivy SP. The revised common toxicity criteria: version 2.0. CTEP 2001 [online]. Available from URL: http://ctep.info.nih.gov [Accessed 2004 Mar 3]
68. Bye A, Ose T, Kaasa S. Quality of life during pelvic radiotherapy. Acta Obstet Gynecol Scand 1995; 74: 147-52
69. Klee M, Thranov I, Machin D. Life after radiotherapy: the psychological and social effects experienced by women treated for advanced stages of cervical cancer. Gynecol Oncol 2000; 76: 5-13
70. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997; 350: 535-40
71. Rotman M, Pajak M, Choi K, et al. Prophylactic extended-field irradiation of paraaortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas: ten-year treatment results of RTOG 79-20. JAMA 1995; 274: 387
72. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-5
73. Tan LT, Jones B, Green JA, et al. Treatment of carcinomas of the uterine cervix which remain bulky after initial external beam radiotherapy: a pilot study using integrated cytotoxic chemotherapy prior to brachytherapy. Br J Radiol 1996; 69: 165-71
74. Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 2003; 39: 2470-86
75. Pignata S, Frezza P, Tramontana S, et al. Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri. Ann Oncol 2000; 4: 455
76. Malfetano JA, Keys H, Cunningham MJ, et al. Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma. Gynecol Oncol 1997; 67: 203-7